Cargando…

A Multicenter Study of 239 Patients Aged Over 70 Years With Diffuse Large B-Cell Lymphoma in China

Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma subtype worldwide and occurs frequently in the elderly population. However, there are limited data on the clinical profiles of patients with DLBCL over 70 years of age. Our objective was to summarize the clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chunli, Li, Qiaoer, Xie, Ke, Zhang, Yakun, Xiang, Dania, Han, Yunwei, Zou, Liqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341248/ https://www.ncbi.nlm.nih.gov/pubmed/35924064 http://dx.doi.org/10.3389/fphar.2022.953808

Ejemplares similares

Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma
por: Chen, Xi, et al.
Publicado: (2022)

RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma
por: Xu, Cong, et al.
Publicado: (2022)

Correlation Between C-MYC, BCL-2, and BCL-6 Protein Expression and Gene Translocation as Biomarkers in Diagnosis and Prognosis of Diffuse Large B-cell Lymphoma
por: Zhang, YunXiang, et al.
Publicado: (2019)

Impact of Qi-Invigorating Traditional Chinese Medicines on Diffuse Large B Cell Lymphoma Based on Network Pharmacology and Experimental Validation
por: Huang, Qian, et al.
Publicado: (2021)

Case Report: Diffuse Large B Cell Lymphoma After Cardiac Transplantation due to Anthracycline-Induced Dilated Cardiomyopathy in Pediatric Acute Lymphoblastic Leukemia
por: Xin, Ning, et al.
Publicado: (2022)

A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma
por: Phillips, Tycel, et al.
Publicado: (2018)

Influence of Statins on the Survival Outcomes of Patients with Diffuse Large B Cell Lymphoma: A Systematic Review and Meta-Analysis
por: Li, Yanbing, et al.
Publicado: (2022)

TEOA Inhibits Proliferation and Induces DNA Damage of Diffuse Large B-Cell Lymphoma Cells Through Activation of the ROS-Dependent p38 MAPK Signaling Pathway
por: Yu, Xingxing, et al.
Publicado: (2020)

Corrigendum: TEOA inhibits proliferation and induces DNA damage of diffuse large B-cell lymphoma cells through activation of the ROS-dependent p38 MAPK signaling pathway
por: Yu, Xingxing, et al.
Publicado: (2022)

Outcomes in refractory diffuse large B‐cell lymphoma: results from a multicenter real‐world study in China
por: Wang, Shuo, et al.
Publicado: (2021)

Call for Decision Support for High-Alert Medication Administration Among Pediatric Nurses: Findings From a Large, Multicenter, Cross-Sectional Survey in China
por: He, Mengxue, et al.
Publicado: (2022)

Letter to members of the SPSC: P239
por: CERN. Geneva. SPS Experiments Committee
Publicado: (1989)

IAU Symposium 239 : Convection in Astrophysics
Publicado: (2006)

GLAST: 239 Days till Launch
por: Atwood, William B
Publicado: (2007)

Health Tract, No. 239: Domestic Cleanliness
Publicado: (1866)

Corticosteroid Use in the Treatment of COVID-19: A Multicenter Retrospective Study in Hunan, China
por: Ma, Yiming, et al.
Publicado: (2020)

Performance Assessment of 239 Series Sub-cooling Heat Exchangers for the Large Hadron Collider
por: Riddone, G, et al.
Publicado: (2006)

Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1
por: Chen, Gui-hao, et al.
Publicado: (2017)

Ovary involvement of diffuse large B-cell lymphoma
por: Hu, Rong, et al.
Publicado: (2012)

Methyl Jasmonate Cytotoxicity and Chemosensitization of T Cell Lymphoma In Vitro Is Facilitated by HK 2, HIF-1α, and Hsp70: Implication of Altered Regulation of Cell Survival, pH Homeostasis, Mitochondrial Functions
por: Goel, Yugal, et al.
Publicado: (2021)

Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China
por: Xu, Jiqian, et al.
Publicado: (2020)

A Multicenter Retrospective Study of 58 Patients With Primary Thyroid Diffuse Large B Cell Lymphoma
por: Yi, Jianing, et al.
Publicado: (2020)

MD 239 on Collide and Squeeze (part 2)
por: Gorzawski, Arkadiusz, et al.
Publicado: (2016)

239. Sex Differences in Prosthetic Joint Infection
por: Mironenko, Christine M, et al.
Publicado: (2021)

THU239 Tolvaptan For SIADH Management In Children
por: Igarashi, Mizuho, et al.
Publicado: (2023)

PB2149: ZANUBRUTINIB IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB VERSUS R-MINICHOP IN UNFIT OR FRAIL PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA AGED OVER OR EQUAL TO 70 YEARS
por: Xu, P., et al.
Publicado: (2022)

Primary diffuse large B-cell lymphoma in the maxilla: A case report
por: Zou, Haixiao, et al.
Publicado: (2018)

Serious Inadequacies in High Alert Medication-Related Knowledge Among Pakistani Nurses: Findings of a Large, Multicenter, Cross-sectional Survey
por: Salman, Muhammad, et al.
Publicado: (2020)

Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi
por: Storti, Sergio, et al.
Publicado: (2018)

Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients – a matched control multicenter cohort study
por: Ram, Ron, et al.
Publicado: (2021)

Histopathological pattern of lymphomas and clinical presentation and outcomes of diffuse large B cell lymphoma: A multicenter registry based study from India
por: Nimmagadda, Ramesh B. V., et al.
Publicado: (2013)

Characteristics and predictors of malignancy in dermatomyositis: Analysis of 239 patients from northern China
por: Liu, Ying, et al.
Publicado: (2018)

Lenalidomide in Diffuse Large B-Cell Lymphomas
por: Chiappella, Annalisa, et al.
Publicado: (2012)

Treatment of Diffuse Large B Cell Lymphoma
por: Kwak, Jae-Yong
Publicado: (2012)

Lenalidomide in Diffuse Large B-Cell Lymphoma
por: Thieblemont, Catherine, et al.
Publicado: (2012)

Cutaneous diffuse large B‐cell lymphoma
por: Duarte Ribeiro, Filipa, et al.
Publicado: (2017)

Genomics of diffuse large B cell lymphoma
por: Koh, Youngil
Publicado: (2021)

Diffuse Large B-Cell Lymphoma of the Cecum
por: Azad, Farhan, et al.
Publicado: (2023)

Automatic Detection of Age-Related Macular Degeneration Based on Deep Learning and Local Outlier Factor Algorithm
por: He, Tingting, et al.
Publicado: (2022)

Superpixel-Oriented Label Distribution Learning for Skin Lesion Segmentation
por: Zhou, Qiaoer, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g8v1k4audb2f6cv3qbf0if1fr7